Technetium, a diagnostic workhorse, provides high definition images with minimal radiation. But its supply could dry up tomorrow.
Disease foundations that use a venture capital model get a stake in the breakthroughs they fund. Not everyone thinks that’s a good idea.
Advocates of shared decision making argue that everyone benefits when patients know more and don’t just follow doctors’ orders.
Peter L. Slavin and David F. Torchiana discuss the research value of micro-organ models.
In an excerpt from physician Danielle Ofri's latest book, a heroin addict makes a group of medical residents re-think their assumptions.